Can a Pre-Incision pain pump transform heart surgery recovery?
NCT ID NCT04495504
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests whether placing thin catheters alongside the breastbone before a heart surgery incision and delivering the numbing drug ropivacaine can reduce pain after the operation. Adults under 85 having planned heart surgery through a sternotomy may receive this continuous local anesthetic for the first 48 hours after surgery. The goal is to see if this method keeps pain scores low and reduces the need for opioid painkillers, potentially improving comfort and shortening recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ropivacaine
- What this could lead to
- If effective, this approach could reduce pain and opioid use after heart surgery, potentially speeding recovery and shortening hospital stays.
- What could go wrong
- The trial is small and early, so results may not apply broadly. Risks include catheter-related complications or inadequate pain relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE UNDER 85 YEARS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clermont-Ferrand - Service de Chirurgie Cardio-Vasculaire
Clermont-Ferrand, Puy de Dôme, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.